Saxon Interests’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$812K Sell
883
-261
-23% -$265K 0.28% 90
2025
Q4
$1.23M Sell
1,144
-12
-1% -$11.5K 0.43% 59
2025
Q3
$847K Buy
1,156
+631
+120% +$470K 0.33% 71
2025
Q2
$434K Hold
525
0.2% 112
2025
Q1
$434K Buy
525
+161
+44% +$134K 0.2% 112
2024
Q4
$281K Sell
364
-80
-18% -$66.2K 0.12% 146
2024
Q3
$393K Buy
444
+105
+31% +$94.4K 0.18% 118
2024
Q2
$307K Buy
339
+4
+1% +$3.2K 0.15% 134
2024
Q1
$261K Buy
+335
New +$238K 0.12% 150

Other funds holding LLY

Saxon Interests's LLY Position: Q1 2026 in Review

Saxon Interests reduced its Eli Lilly (LLY) stake by 23% in Q1 2026, selling an estimated $265K and leaving 883 shares worth $812K. The position accounts for 0.28% of the portfolio, ranked #90.

Saxon Interests first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.23M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Saxon Interests held 883 shares of Eli Lilly worth $812K as of Q1 2026.
  • Saxon Interests sold 261 Eli Lilly shares in Q1 2026, an estimated $265K.
  • Eli Lilly made up 0.28% of Saxon Interests's portfolio in Q1 2026, its #90 holding.
  • Saxon Interests first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Saxon Interests's Eli Lilly position peaked at $1.23M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Saxon Interests's 13F filing for Q1 2026, filed 29 Apr 2026.